AzTrials
AzTrials

Pancreatitis,Acute NecrotizingREALAXIOSNCT04782414

Hot AXIOS® Prosthesis in Real Life Conditions -

An observational study of Pancreatitis,Acute Necrotizing, run by Centre Hospitalier Universitaire de Nice at 17 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Regulatory Context The CNEDiMTS makes the renewal of registration conditional on the transmission of the results of a well-conducted prospective study, carried out with Hot AXIOS, the objective of which is to evaluate the interest of this device in real conditions of use with regard to effectiveness and complications… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Pancreatitis,Acute Necrotizing
What is being tested?
Hot AXIOS® prosthesis
Type of treatment
Surgery or procedure
How many people
176 participants
Where
17 sitesFrance
Study dates
18 Apr 2021to 9 Nov 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: patients having benefited from the treatment of pancreatic collections

Who may be able to join

  • Should benefit from the installation of a Hot Axios system as part of PBDA support, regardless of the indication.
  • Age ≥ 18 years old,
  • Having signed his or her no objection or the trusted person if the patient is unable to do so prior to the procedure
  • Affiliated to a social security scheme

Who cannot join

  • Patients who have indicated that they do not wish to participate in the study.

Trial locations and contacts

17 sites in 1 country.

17 sites in 1 country

France17 sites
  • Avignon Hospital

    Avignon, 84000

  • brest Hospital

    Brest, 29603

  • Clermont-ferrand hospital

    Clermont-Ferrand, 63003

  • Polyclinique Saint Côme

    Compiègne, 60204

  • Lille Hospital

    Lille, 59037

  • Limoges hospital

    Limoges, 87042

  • Clinique Jean Mermoz

    Lyon, 69008

  • APHM

    Marseille, 13000

  • European Hospital

    Marseille, 13000

  • St Joseph Hospital

    Marseille, 13000

  • Nancy Hospital

    Nancy

  • Nice Hospital

    Nice, 06000

  • APHP saint antoine

    Paris, 75012

  • Hôpital privé des peupliers

    Paris, 75013

  • Poitiers Hospital

    Poitiers, 86021

  • Saint Etienne Hospital

    Saint-Etienne, 42055

  • Centre Hospitalier Jacques Lacarin

    Vichy, 03207

Other trials in France

About this study

Official title: Observational Study of Patients Treated With Hot AXIOS® Prosthesis in Real Life Conditions -

Regulatory Context The CNEDiMTS makes the renewal of registration conditional on the transmission of the results of a well-conducted prospective study, carried out with Hot AXIOS, the objective of which is to evaluate the interest of this device in real conditions of use with regard to effectiveness and complications after a minimum follow-up of 3 months.

Operators are trained in the use of the equipment (practice on ex-vivo model and/or prior stent placement) and undertake to comply with the rules and formalities of use.

Read more

Primary efficacy objective :

To evaluate the efficacy of endoscopic trans digestive drainage after use of the Hot AXIOS prosthesis in the treatment of pancreatic collections (incompletely fluid or necrotic) at 3 months.

Secondary Objectives :

Assessment of the following elements :

  1. Morbidity (complication rates) and mortality per- and post-procedure
  2. Recurrence rate of pancreatic collection
  3. Evolution of the quality of life questionnaire (SQ5D5L)
  4. Technical success rate of prosthesis placement and removal success rate of the prosthesis
  5. Search for factors predictive of clinical success of endoscopic pancreatic drainage with the Hot Axios prosthesis.

Study design Non-interventional/observational (RIPH 3 type), multi-center, prospective study with consecutive inclusions evaluating the Hot AXIOS® prosthetic device.

Non-inclusion registry A minimum amount of information will be collected anonymously, including sex, age, indication of drainage and reason for non-inclusion (e.g. refusal of the patient, of the investigator for impossibility of following the patient in the centre or other reasons to be specified). Generic information will be affixed in each centre participating in the study indicating: "In application of the provisions of the Data Protection Act, general information on the possibility that personal data may be used for research purposes must be provided in any establishment or centre where prevention, diagnosis and care activities are carried out". This must be exhaustive and rigorously maintained.

Equipment used in endoscopy Hot AXIOS™ - self-expanding metal prosthesis with a lumen diameter of 6 to 20 mm and collar length of 8 and 10 mm or any future similar device marketed under the same name at the time of the study.

Technique Insertion of the material under echo-endoscopic control -- possible but not systematic dilatation -- guide wire with hydrophilic tip - Puncture and release under echo-endoscopic control according to the centre's usual practice.

Registration The data will be collected anonymously in an electronic computer database using eCRFs.

Statistical analysis The evaluation of the clinical success of endoscopic pancreatic necrosectomy with metallic prosthesis will first consist in describing its efficacy according to the criteria described above.

Analysis plan :

The statistical analysis will first include a description of the study population with the number of patients falling under the indication and treated with the Hot AXIOS system at the recruiting centers (source population), the number of eligible patients who consented to participate in the study, the number of patients included (study population), the number of subjects who made each visit and were analyzed, premature exits (deaths, lost to follow-up) will be reported and described in the form of a flow chart.

Being tested
Hot AXIOS® prosthesis
Medical subject headings
Pancreatitis, Acute Necrotizing

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hot AXIOS® prosthesisProcedure or surgery

    endoscopic trans digestive drainage using of the Hot AXIOS prosthesis in the treatment of pancreatic collections (incompletely fluid or necrotic)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. patients with clinical success

    reduction in the size of the pancreatic fluid collection ≤ 3 cm, evaluated by imaging

    Measured: 3 months

Secondary outcomes (5)
  1. Collect all complications,

    Complications will be assessed according to Cotton's endoscopic classification26 (mild, moderate, severe, or fatal) [Cotton PB, Eisen GM, Aabakken L, et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc.2010; 71: 446-54].

    Measured: 3 months

  2. recurrence of pancreatic collection

    the presence of a collection of pancreatic origin on imaging of more than 3 cm at the 3-month check-up

    Measured: 3 months

  3. evolution of the quality of life questionnaire

    Analyze the evolution of the quality of life questionnaire EQ5D5L, with as reference the one completed before the procedure

    Measured: 3 months

  4. Evaluate the technical success rate

    success of the prosthesis in place at the end of the endoscopic procedure - determined by the correct trans parietal (gastric or duodenal) deployment (collar on either side of the digestive walls) and the technical success rate of the prosthesis removal (endoscopic extraction) and the date of the procedure.

    Measured: 3 months

  5. Look for factors predictive of clinical success

    the predictive factors will be an aggregate of the folowing clinicals signs

    1. sex, age, body mass index, severity score (APACHE II), aetiology of pancreatitis, size of collection, proportion of solid debris in the collection, associated pancreatic ductal rupture, glandular extension and peritoneal extension of the necrosis , location of the gastrostomy , time between admission and completion of the procedure
    2. According to the clinical signs that motivated the intervention such as :
    3. Pain and/or, ii. Necrosis infection (positive culture of necrosis, presence of gas bubbles in the collection on imaging, persistent sepsis or deterioration of the patient's condition malgré́ an optimal resuscitation support without documented infection) and/or, iii. High occlusion (vomiting, food intolerance and gastric stasis on imaging) and/or, iv. Symptoms such as jaundice and/or, v. Organ failures such as kidney, heart, lung.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Mar 2021
  2. Study start18 Apr 2021
  3. Primary completion9 Nov 2023
  4. Study completion9 Nov 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
176 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04782414
Sponsor's protocol ID
19-PP-20
Acronym
REALAXIOS
Status last verified
May 2024
First submitted
1 Mar 2021
Last updated
17 May 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Pancreatitis,Acute Necrotizing, run by Centre Hospitalier Universitaire de Nice at 17 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 17 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

patients with clinical success (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in